Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302272 · ClinicalTrials.gov registry record
STRIVE Post-Market Registry Study
A clinical trial of Emphysema, sponsored by Olympus Corporation of the Americas.
- Recruiting
- Registry status
- 150
- Enrollment target
- 13
- Study locations
NCT04302272: Recruiting study of Emphysema, sponsored by Olympus Corporation of the Americas.
NCT04302272 is a study of Emphysema that is actively recruiting participants, run by Olympus Corporation of the Americas. The registered enrollment target is 150 participants, below the 3,797-participant average among 25 other Emphysema trials with a reported enrollment target (96% lower). The trial reports 13 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04302272, a study of Emphysema, is actively recruiting participants, sponsored by Olympus Corporation of the Americas.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 13
- Study locations
Study Summary
This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
Primary Outcome
The primary safety endpoint will be the incidence of device-related and procedure-related pre-specified thoracic adverse events of special interest (TAEsSI) through 12 months following the first implantation procedure.
Conditions Studied
Interventions
- DEVICE Spiration Valve System (SVS)
Study Locations (13)
Illinois
- Northwestern University, Division of Pulmonary and Critical Care Medicine - Chicago
- University of Chicago - Chicago
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
- Temple University - Philadelphia
Texas
- Baylor Scott & White Research Institute - Dallas
- University of Texas Southwestern - Dallas
Arizona
- Dignity Health St. Joseph's Hospital and Medical Center - Phoenix
California
- El Camino, Taft Center for Clinical Research - Mountain View
Louisiana
- LSU Health Shreveport - Shreveport
Massachusetts
- Beth Israel Decaconess - Boston
Mississippi
- Memorial Hospital at Gulfport - Gulfport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-10-09 |
| Est. Completion | 2028-04 |
What NCT04302272 shows while recruiting
NCT04302272 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 3,797-participant average among 25 other Emphysema trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Emphysema appearing as the primary indexed condition, and to 1 intervention - of which Spiration Valve System (SVS) is the first listed.
NCT04302272 lists 13 locations in 10 states (Illinois, Pennsylvania, Texas).
Frequently Asked Questions
What is clinical trial NCT04302272 about?
NCT04302272 is a clinical study titled "STRIVE Post-Market Registry Study". This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
What is the current status of trial NCT04302272?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-10-09. Estimated completion is 2028-04.
What conditions does trial NCT04302272 study?
This clinical trial studies the following conditions: Emphysema.
What interventions are being tested in trial NCT04302272?
The interventions under investigation include: Spiration Valve System (SVS) (DEVICE).
Who is sponsoring clinical trial NCT04302272?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04302272 being conducted?
This trial has 13 study locations across Arizona, California, Illinois, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emphysema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04302272's enrollment target sits among peer trials
150 12th of 25 higher than 13 of 25 other Emphysema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Emphysema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COPD Patient-Powered Research Network
RECRUITING
-
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
RECRUITING
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
RECRUITING · Phase 2
-
Biological Effects of Quercetin in COPD Phase II
RECRUITING · Phase 2
-
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
RECRUITING · NA
-
Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI